糖化血红蛋白水平与大血管闭塞机械取栓患者临床结局的关系
这项前瞻性队列研究纳入534例接受机械取栓的大血管闭塞急性缺血性卒中患者,按HbA1c水平分析3个月改良Rankin量表评分。HbA1c>6.5%者获得良好结局的比例显著低于HbA1c≤6.5%者(28.8% vs 42.1%,P=0.006),多因素分析显示高HbA1c(尤其>7.0%)与3个月不良功能结局独立相关,并与死亡率和早期临床结局恶化相关。
要点
- HbA1c>6.5%者取栓后3个月功能独立比例显著低于HbA1c≤6.5%者。
- 高HbA1c是取栓后3个月不良结局的独立预测因素,尤其HbA1c>7.0%时。
- 高HbA1c还与死亡率增加和早期临床结局恶化相关。
核心结论
- 高HbA1c水平是大血管闭塞机械取栓患者3个月不良结局的独立预测因素,尤其在血管再通患者中。
- 高HbA1c可能增加卒中后死亡率和早期临床恶化风险。
研究设计与样本
- 前瞻性队列研究,纳入534例接受机械取栓的急性缺血性卒中大血管闭塞患者。
- 高HbA1c定义为血浆HbA1c>6.5%,良好结局定义为改良Rankin量表评分0–2分。
主要发现
- HbA1c>6.5%者良好结局比例为28.8%,HbA1c≤6.5%者为42.1%(P=0.006)。
- 多因素分析显示高HbA1c(尤其>7.0%)与3个月不良功能结局显著相关。
- 高HbA1c与死亡率增加和早期临床结局恶化显著相关。
- 亚组分析显示HbA1c>6.5%与3个月功能独立几率降低相关,见于再通组与非再通组比较。
关键数值与推荐
- 高HbA1c定义:血浆HbA1c>6.5%。
- 良好结局定义:改良Rankin量表评分0–2分。
- HbA1c>6.5%者良好结局28.8% vs HbA1c≤6.5%者42.1%(P=0.006)。
临床怎么用
- 对拟行机械取栓的大血管闭塞患者,可检测HbA1c以辅助评估3个月功能预后。
- HbA1c>6.5%尤其>7.0%提示取栓后不良结局和死亡风险较高,可加强围手术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- We analyzed the relationship between HbA1c (glycated hemoglobin) levels and clinical outcomes in patients with large vessel occlusion treated with mechanical thrombectomy (MT). Methods- A total of 534 patients with acute ischemic stroke (AIS) treated with MT were enrolled in this prospective cohort study. The primary outcome measured was the modified Rankin Scale score at 3 months, according to HbA1c level. High HbA1c levels were defined as a plasma level of HbA1c >6.5%. Favorable outcomes were defined as functional independence, with modified Rankin Scale scores of 0 to 2. Secondary functional outcomes included mortality, early clinical outcomes, and intracranial hemorrhage. Results- The number of patients with a favorable outcome was significantly lower in patients with HbA1c >6.5% than in those with HbA1c ≤6.5% (28.8% versus 42.1%; P=0.006). In multivariate analysis, high HbA1c levels (especially >7.0% HbA1c) were significantly associated with poor functional outcomes 3 months after AIS in patients with large vessel occlusion treated with MT. High HbA1c was also significantly associated with increased mortality and worse early clinical outcomes after AIS in patients treated with MT. Subgroup analyses showed that HbA1c >6.5% was associated with significantly lower odds of functional independence at 3 months after AIS, when comparing the recanalized group with nonrecanalized patients. Conclusions- These results suggest that high HbA1c level is an independent predictor of a poor outcome at 3 months after AIS in patients with large vessel occlusion treated with MT, particularly in those with recanalization, and may augment the risk of mortality and early clinical worsening after AIS.
引用
- Choi KH, Kim JH, Kang KW, et al. HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome Post-Mechanical Thrombectomy in Patients With Large Vessel Occlusion. Stroke. 2018. PMID: 30580713. doi:10.1161/STROKEAHA.118.021598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。